CN1778199A - 孕产妇营养素 - Google Patents
孕产妇营养素 Download PDFInfo
- Publication number
- CN1778199A CN1778199A CNA200410084789XA CN200410084789A CN1778199A CN 1778199 A CN1778199 A CN 1778199A CN A200410084789X A CNA200410084789X A CN A200410084789XA CN 200410084789 A CN200410084789 A CN 200410084789A CN 1778199 A CN1778199 A CN 1778199A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- brewer
- wort
- yeast
- woman
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015097 nutrients Nutrition 0.000 title claims description 19
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 27
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000011669 selenium Substances 0.000 claims abstract description 15
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 15
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 14
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 12
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000011701 zinc Substances 0.000 claims abstract description 10
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 10
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960000304 folic acid Drugs 0.000 claims abstract description 7
- 235000019152 folic acid Nutrition 0.000 claims abstract description 7
- 239000011724 folic acid Substances 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims abstract description 7
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 6
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims abstract description 6
- 229960002685 biotin Drugs 0.000 claims abstract description 6
- 235000020958 biotin Nutrition 0.000 claims abstract description 6
- 239000011616 biotin Substances 0.000 claims abstract description 6
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 6
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 6
- 235000011010 calcium phosphates Nutrition 0.000 claims abstract description 6
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960001231 choline Drugs 0.000 claims abstract description 6
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims abstract description 6
- 235000013925 ferrous lactate Nutrition 0.000 claims abstract description 6
- 239000004225 ferrous lactate Substances 0.000 claims abstract description 6
- 229940037907 ferrous lactate Drugs 0.000 claims abstract description 6
- 229940099596 manganese sulfate Drugs 0.000 claims abstract description 6
- 235000007079 manganese sulphate Nutrition 0.000 claims abstract description 6
- 239000011702 manganese sulphate Substances 0.000 claims abstract description 6
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims abstract description 6
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 6
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 6
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 6
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 6
- 229940091258 selenium supplement Drugs 0.000 claims description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 229960001471 sodium selenite Drugs 0.000 claims description 9
- 235000015921 sodium selenite Nutrition 0.000 claims description 9
- 239000011781 sodium selenite Substances 0.000 claims description 9
- 238000010792 warming Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000005469 granulation Methods 0.000 claims description 6
- 230000003179 granulation Effects 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- 229930003471 Vitamin B2 Natural products 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- 235000013734 beta-carotene Nutrition 0.000 claims description 5
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 5
- 239000011648 beta-carotene Substances 0.000 claims description 5
- 229960002747 betacarotene Drugs 0.000 claims description 5
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 229960003512 nicotinic acid Drugs 0.000 claims description 5
- 235000001968 nicotinic acid Nutrition 0.000 claims description 5
- 239000011664 nicotinic acid Substances 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 235000019164 vitamin B2 Nutrition 0.000 claims description 5
- 239000011716 vitamin B2 Substances 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 5
- 229930003451 Vitamin B1 Natural products 0.000 claims description 4
- 229960003495 thiamine Drugs 0.000 claims description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 4
- 235000010374 vitamin B1 Nutrition 0.000 claims description 4
- 239000011691 vitamin B1 Substances 0.000 claims description 4
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 235000013312 flour Nutrition 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 235000020985 whole grains Nutrition 0.000 claims description 3
- 241000209140 Triticum Species 0.000 claims 1
- 235000021307 Triticum Nutrition 0.000 claims 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims 1
- 210000003754 fetus Anatomy 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 4
- 210000004556 brain Anatomy 0.000 abstract description 2
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 abstract 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 229910000365 copper sulfate Inorganic materials 0.000 abstract 1
- 230000000050 nutritive effect Effects 0.000 abstract 1
- 239000011573 trace mineral Substances 0.000 description 8
- 235000013619 trace mineral Nutrition 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- 150000003722 vitamin derivatives Chemical class 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 7
- 230000035764 nutrition Effects 0.000 description 5
- 230000004641 brain development Effects 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000035935 pregnancy Effects 0.000 description 4
- 230000001605 fetal effect Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 208000001362 Fetal Growth Retardation Diseases 0.000 description 2
- 206010070531 Foetal growth restriction Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 208000030941 fetal growth restriction Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 230000008271 nervous system development Effects 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 208000009206 Abruptio Placentae Diseases 0.000 description 1
- 206010002065 Anaemia megaloblastic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010016880 Folate deficiency Diseases 0.000 description 1
- 208000010188 Folic Acid Deficiency Diseases 0.000 description 1
- 206010070538 Gestational hypertension Diseases 0.000 description 1
- 201000005624 HELLP Syndrome Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000000682 Megaloblastic Anemia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000002787 Pregnancy Complications Diseases 0.000 description 1
- 208000005347 Pregnancy-Induced Hypertension Diseases 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 208000003107 Premature Rupture Fetal Membranes Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 208000010238 Uterine Inertia Diseases 0.000 description 1
- 206010046763 Uterine atony Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 231100001016 megaloblastic anemia Toxicity 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 201000000977 neonatal anemia Diseases 0.000 description 1
- 210000000276 neural tube Anatomy 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 201000008532 placental abruption Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 208000036335 preeclampsia/eclampsia 1 Diseases 0.000 description 1
- 208000012113 pregnancy disease Diseases 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种孕产妇营养素，该孕产妇营养素的组分包括生物磷酸钙、乳酸亚铁、酵母锌、酵母硒、硫酸锰、硫酸铜、碘化钾、维生素A、维生素D、维生素E、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、泛酸、叶酸、烟酸、胆碱、生物素、β－胡萝卜素。制备方法如下：制作酵母硒和酵母锌，将上述各原料按比例混合，搅拌均匀，造粒，将造粒好的混合料进行整粒，压片、包衣。本发明为一种保健食品制剂，服用方便，营养齐全，服用该营养素后，可以保证怀孕期间及产后期间所必需的微量元素和维生素的摄入，以满足孕产妇身体营养的需要，及保证胎幼儿身体良好发育，尤其是大脑发育的需要。
Description
技术领域
本发明涉及为孕产妇提供营养素的保健食品领域，尤其是指一种孕产妇营养素。
背景技术
妊娠期母体各系统皆发生变化，血容量与循环血量增加，心率加速，使心脏负担增大；呼吸加快，上呼吸道粘膜增厚，常有水肿，易于感染；胃酸减少，胃肠蠕动减慢，易产生胀气、便秘、食欲不佳；肾脏需排泄母子双方的代谢产物而负担加重；子宫与乳房增大，增大的子宫易压迫输尿管而致泌尿系统容易感染；甲状腺功能旺盛，新陈代谢率增加，故多种营养素需要量增加，孕妇又要储存脂肪及多种营养素以备临产时、产后，哺乳期的消耗。孕妇营养素缺乏可对母体及胎儿产生不良影响，可致母体虚弱，易于发生各种妊娠合并症，如妊娠期贫血、妊娠高血压综合征、甲状腺肿大，并可引致产科异常情况，如死胎、流产、胎膜早破、宫缩无力及产后出血等症状；并可影响胎盘结构与功能，从而减弱胎盘向胎儿输送营养成分的作用。某些营养素严重缺乏可致畸胎，一般营养缺乏可致胎儿宫内发育迟缓，出生低体重，同时脑发育也受影响，智力发育落后。
营养学和孕产生理学研究证明：妇女在怀孕以后，尤其怀孕四个月后，孕妇对各种营养素的需求量急剧增加，以满足胎儿生长发育的需要。蛋白质、碳水化合物、脂肪以及钙、钾、磷等常量元素，可以从增加食物的摄入量得到满足，但微量元素及维生素，孕妇普遍存在缺少的现象。
临床生理学研究证明：微量元素和维生素对胎儿生长发育有重要影响，例铁的缺少，会引起孕妇贫血和新生儿贫血；锌的缺少，会影响胎儿的神经系统发育；叶酸缺乏会引起先兆子痫、胎盘早剥，还会引起巨幼红细胞贫血及胎儿宫内发育迟缓、早产及新生儿体重过低。怀孕早期缺乏叶酸易引起胎儿神经管畸形。
神经系统发育生理学研究证明：人的大脑发育有二个关键期：十月怀胎期和三岁前。而某些微量元素和维生素对胎、幼儿大脑发育有极重要影响。因此，怀孕期间及产后期间必须保证微量元素和维生素的摄入。产妇乳汁微量元素和维生素含量取决于产妇食物中摄入的量。因此，产妇每日需摄入足够量的微量元素和维生素，以满足幼儿的身体发育，尤其是大脑发育的需要。
目前，市面上有关孕产妇补充各种营养素的产品种类繁多，但大都营养单一，需同时服用多种营养素才能满足孕产妇所需要的各种营养，这样给孕产妇带来很大不便。
发明内容
本发明提供了一种孕产妇专用的含有各种微量元素及维生素的保健食品制剂。
本发明的技术方案是这样的：该孕产妇营养素的组分及配比(重量比％)为：生物磷酸钙50-60；乳酸亚铁2-3；酵母锌5-6；酵母硒0.5-1.0；硫酸锰1-2；硫酸铜0.01-0.02；碘化钾0.01-0.02；维生素A 0.01-0.05；维生素D 0.001-0.002；维生素E 0.5-1.0；维生素B1 0.05-0.10；维生素B2 0.08-0.15；维生素B6 0.10-0.15；维生素B12 0.0002-0.0003；维生素C5-10；泛酸0.3-0.5；叶酸0.03-0.05；烟酸0.5-1.0；胆碱20-30；生物素0.001-0.003；β-胡萝卜素0.1-0.5。
按上述组分及配比来配制孕产妇营养素的制备方法包括以下步骤：
A.制作酵母硒：a.制备酵母发酵麦芽汁，将优质麦芽粉碎，按1∶4比例，将麦芽粉与水混合，在水浴锅里升温至48-50℃，保温50-60分钟，再升温至60-70℃，保温20-30分钟，最后升温至75-80℃，保温10-15分钟，过滤后得到浓度为12-16°ρ的麦芽汁，将该麦芽汁稀释到12°ρ备用；b.将亚硒酸钠溶解，加入到麦芽汁中，搅拌均匀，制得每1000ml麦芽汁中含有亚硒酸钠1-6g的混和物；c.将逐级扩大培养的酵母加入到发酵缸中，在25-29℃的温度下，将麦芽汁与亚硒酸钠的混和物发酵48-72小时；d.将发酵后的混和物离心分离并干燥，即得酵母硒；
B.酵母锌制作方法与酵母硒同；
C.将上述各原料按比例混合，搅拌均匀，造粒；
D.将造粒好的混合料进行整粒；
E.压片、包衣。
本发明的有益效果是：孕产妇需要的各种营养素制成一种保健食品制剂，服用方便，营养齐全；服用该营养素后，可以保证怀孕期间及产后期间所必需的微量元素和维生素的摄入，以满足孕产妇身体营养的需要，及保证胎幼儿身体良好发育，尤其是大脑发育的需要。
具体实施方式
下面通过实施例对本发明的技术方案作进一步具体的说明。
实施例1：该孕产妇营养素的组分及配比(重量比％)为：生物磷酸钙50；乳酸亚铁2；酵母锌5；酵母硒0.5；硫酸锰2；硫酸铜0.01；碘化钾0.02；维生素A 0.01；维生素D 0.001；维生素E 0.5；维生素B1 0.05；维生素B2 0.08；维生素B6 0.1；维生素B12 0.0003；维生素C 10；泛酸0.3；叶酸0.04；烟酸0.5；胆碱25；生物素0.001；β-胡萝卜素0.1。
本发明的制备方法包括以下步骤：制作酵母硒：a.制备酵母发酵麦芽汁，将优质麦芽粉碎，按1∶4比例，将麦芽粉与水混合，在水浴锅里升温至48-50℃，保温50-60分钟，再升温至60-70℃，保温20-30分钟，最后升温至75-80℃，保温10-15分钟，过滤后得到浓度为12-16°ρ的麦芽汁，将该麦芽汁稀释到12°ρ备用；b.将亚硒酸钠溶解，加入到麦芽汁中，搅拌均匀，制得每1000g麦芽汁中含有亚硒酸钠1-6g的混和物；c.将逐级扩大培养酵母加入到发酵缸中，在25-29℃的温度下，将麦芽汁与亚硒酸钠的混和物发酵48-72小时；d.将发酵后的混和物离心分离并干燥，即得酵母硒；酵母锌制作方法与酵母硒同；将上述各原料按比例混合，搅拌均匀，造粒；将造粒好的混合料进行整粒；压片、包衣。
实施例2：该孕产妇营养素的组分及配比(重量比％)为：生物磷酸钙55；乳酸亚铁2.5；酵母锌6；酵母硒0.8；硫酸锰1.5；硫酸铜0.02；碘化钾0.015；维生素A 0.02；维生素D 0.0015；维生素E 0.7；维生素B1 0.08；维生素B2 0.10；维生素B6 0.15；维生素B12 0.00025；维生素C 5；泛酸0.4；叶酸0.05；烟酸1.0；胆碱20；生物素0.002；β-胡萝卜素0.2。
其余参考实施例1。
实施例3：该孕产妇营养素的组分及配比(重量比％)为：生物磷酸钙52；乳酸亚铁3；酵母锌5.5；酵母硒0.06；硫酸锰2；硫酸铜0.015；碘化钾0.01；维生素A 0.015；维生素D 0.002；维生素E 1.0；维生素B10.1；维生素B2 0.12；维生素B6 0.15；维生素B12 0.0002；维生素C 10；泛酸0.5；叶酸0.03；烟酸0.8；胆碱30；生物素0.003；β-胡萝卜素0.3。
其余参考实施例1。
最后，应当指出，以上实施例仅是本发明较有代表性的例子。显然，本发明的技术方案并不限于上述实施例，还可以有许多变形。本领域的普通技术人员能从本发明公开的内容直接导出或联想到的所有变形，均应认为是本发明的保护范围。
Claims (2)
1、一种孕产妇营养素，其特征在于其组分及配比(重量比％)为：
生物磷酸钙 50-60
乳酸亚铁 2-3
酵母锌 5-6
酵母硒 0.5-1.0
硫酸锰 1-2
硫酸铜 0.01-0.02
碘化钾 0.01-0.02
维生素A 0.01-0.05
维生素D 0.001-0.002
维生素E 0.5-1.0
维生素B1 0.05-0.10
维生素B2 0.08-0.15
维生素B6 0.10-0.15
维生素B12 0.0002-0.0003
维生素C 5-10
泛酸 0.3-0.5
叶酸 0.03-0.05
烟酸 0.5-1.0
胆碱 20-30
生物素 0.001-0.003
β-胡萝卜素 0.1-0.5
2、根据权利要求1所述的组分及配比来制作孕产妇营养素的制备方法，其特征在于包括以下步骤：
A.制作酵母硒：
a.制备酵母发酵麦芽汁，将优质麦芽粉碎，按1∶4比例，将麦芽粉与水混合，在水浴锅里升温至48-50℃，保温50-60分钟，再升温至60-70℃，保温20-30分钟，最后升温至75-80℃，保温10-15分钟，过滤后得到浓度为12-16°ρ的麦芽汁，将该麦芽汁稀释到12°ρ备用；
b.将亚硒酸钠溶解，加入到麦芽汁中，搅拌均匀，制得每1000ml麦牙汁中含有亚硒酸钠1-6g的混和物；
c.将逐级扩大培养的酵母加入到发酵缸中，在25-29℃的温度下，将麦芽汁与亚硒酸钠的混和物发酵48-72小时；
d.将发酵后的混和物离心分离并干燥，即得酵母硒；
B.酵母锌制作方法与酵母硒同；
C.将上述各原料按比例混合，搅拌均匀，造粒；
D.将造粒好的混合料进行整粒；
E.压片、包衣。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA200410084789XA CN1778199A (zh) | 2004-11-24 | 2004-11-24 | 孕产妇营养素 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA200410084789XA CN1778199A (zh) | 2004-11-24 | 2004-11-24 | 孕产妇营养素 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1778199A true CN1778199A (zh) | 2006-05-31 |
Family
ID=36768744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA200410084789XA Pending CN1778199A (zh) | 2004-11-24 | 2004-11-24 | 孕产妇营养素 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1778199A (zh) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102077945A (zh) * | 2010-09-20 | 2011-06-01 | 王强 | 一种人流、产后专用的海洋特膳食品 |
| CN102524401A (zh) * | 2011-12-20 | 2012-07-04 | 光明乳业股份有限公司 | 一种营养素原料组合物,营养素及其制备方法 |
| US8535931B2 (en) | 2008-08-29 | 2013-09-17 | Tetrahedron | Non-photosynthetic micro-organisms enriched with organic selenium from seleno-hydroxyacid compounds and applications thereof in the field of nutrition, cosmetics and pharmacueuticals |
| CN103519191A (zh) * | 2013-10-28 | 2014-01-22 | 何天富 | 胆碱酵母片 |
| US8846111B2 (en) * | 2007-05-18 | 2014-09-30 | Alltech, Inc. | Compositions and methods for establishing and/or maintaining pregnancy |
| US9017985B2 (en) | 2008-08-29 | 2015-04-28 | Metabolium | Photosynthetic microorganisms enriched in selenium using selenohydroxy acid compounds, used thereof in nutrition, cosmetics and pharmacy |
| CN105166903A (zh) * | 2015-09-25 | 2015-12-23 | 浙江康诺邦健康产品有限公司 | 一种孕妇营养预混料及包含孕妇营养预混料的食品 |
| CN107594540A (zh) * | 2017-11-05 | 2018-01-19 | 耿德铨 | 助孕育营养品复合粉及其制备方法 |
| CN108697672A (zh) * | 2016-03-30 | 2018-10-23 | 雀巢产品技术援助有限公司 | 包含胆碱的组合物及其用途 |
| CN109645486A (zh) * | 2019-01-04 | 2019-04-19 | 达利园医药科技有限公司 | 一种有效补充孕妇营养及促进婴儿生长发育的组方及制备方法 |
| CN110720632A (zh) * | 2019-12-03 | 2020-01-24 | 吉林省红五味生物技术有限公司 | 一种孕晚期营养素组合物及其制备方法与应用 |
| CN110720631A (zh) * | 2019-12-03 | 2020-01-24 | 吉林省红五味生物技术有限公司 | 一种孕中期营养素组合物及其制备方法与应用 |
-
2004
- 2004-11-24 CN CNA200410084789XA patent/CN1778199A/zh active Pending
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8846111B2 (en) * | 2007-05-18 | 2014-09-30 | Alltech, Inc. | Compositions and methods for establishing and/or maintaining pregnancy |
| US20140348872A1 (en) * | 2007-05-18 | 2014-11-27 | Alltech, Inc. | Compositions and methods for establishing and/or maintaining pregnancy |
| US8535931B2 (en) | 2008-08-29 | 2013-09-17 | Tetrahedron | Non-photosynthetic micro-organisms enriched with organic selenium from seleno-hydroxyacid compounds and applications thereof in the field of nutrition, cosmetics and pharmacueuticals |
| US9017985B2 (en) | 2008-08-29 | 2015-04-28 | Metabolium | Photosynthetic microorganisms enriched in selenium using selenohydroxy acid compounds, used thereof in nutrition, cosmetics and pharmacy |
| CN102077945A (zh) * | 2010-09-20 | 2011-06-01 | 王强 | 一种人流、产后专用的海洋特膳食品 |
| CN102077945B (zh) * | 2010-09-20 | 2013-05-01 | 王强 | 一种人流、产后专用的海洋特膳食品 |
| CN102524401A (zh) * | 2011-12-20 | 2012-07-04 | 光明乳业股份有限公司 | 一种营养素原料组合物,营养素及其制备方法 |
| CN103519191A (zh) * | 2013-10-28 | 2014-01-22 | 何天富 | 胆碱酵母片 |
| CN105166903A (zh) * | 2015-09-25 | 2015-12-23 | 浙江康诺邦健康产品有限公司 | 一种孕妇营养预混料及包含孕妇营养预混料的食品 |
| CN105166903B (zh) * | 2015-09-25 | 2018-06-22 | 杭州千岛湖康诺邦健康产品有限公司 | 一种孕妇营养预混料及包含孕妇营养预混料的食品 |
| CN108697672A (zh) * | 2016-03-30 | 2018-10-23 | 雀巢产品技术援助有限公司 | 包含胆碱的组合物及其用途 |
| CN107594540A (zh) * | 2017-11-05 | 2018-01-19 | 耿德铨 | 助孕育营养品复合粉及其制备方法 |
| CN109645486A (zh) * | 2019-01-04 | 2019-04-19 | 达利园医药科技有限公司 | 一种有效补充孕妇营养及促进婴儿生长发育的组方及制备方法 |
| CN110720632A (zh) * | 2019-12-03 | 2020-01-24 | 吉林省红五味生物技术有限公司 | 一种孕晚期营养素组合物及其制备方法与应用 |
| CN110720631A (zh) * | 2019-12-03 | 2020-01-24 | 吉林省红五味生物技术有限公司 | 一种孕中期营养素组合物及其制备方法与应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1778199A (zh) | 孕产妇营养素 | |
| CN101143010B (zh) | 糖尿病患者专用营养食品制备方法 | |
| CN102488011B (zh) | 一种含花生四烯酸的孕产妇配方奶粉及其制备方法 | |
| CN106912689A (zh) | 一种妊娠期饲料添加剂及饲料 | |
| CN104382934A (zh) | 一种孕妇多维片 | |
| CN108371285A (zh) | 纤康复方纤维代谢调节营养代餐粉 | |
| CN102302152A (zh) | 一种营养组合物及其制备方法 | |
| Hummel et al. | Metabolism of Women during the Reproductive Cycle: VII. Utilization of Inorganic Elements (a Continuous Case Study of a Multipara): Three Figures | |
| CN101485693A (zh) | 孕产妇营养素 | |
| AU2024304858A1 (en) | Nutritional composition for pregnant women and preparation method therefor | |
| US20250049872A1 (en) | hypoallergenic milk with immune enhancing function and preparation method thereof | |
| CN102220214B (zh) | 一种雄蛾海参酒及其加工方法 | |
| CN103349143A (zh) | 一种孕妇保健叶酸奶糖 | |
| CN113826815A (zh) | 一种平衡血糖的膳食纤维复合粉及其制备方法 | |
| CN108815269A (zh) | 叶酸葡萄糖酸亚铁维生素c泡腾片及其制备方法和应用 | |
| Kuoppala | Alterations in vitamin D metabolites and minerals in diabetic pregnancy | |
| CN1489918A (zh) | 一种适用于婴幼儿食用的液体奶 | |
| CN108850625B (zh) | 钙缺乏型疾病老鼠模型饲料及其制备方法 | |
| CN107950849B (zh) | 一种产妇电解质能量饮料及其入量管理方法 | |
| CN115399404A (zh) | 空怀和妊娠前期精料配方 | |
| US20240390447A1 (en) | Methods for supplementing iron, promoting iron absorption, and/or improving skin condition by using saskatoon berry extract | |
| CN1596737A (zh) | 一种保健营养液及其制备方法 | |
| CN109757657A (zh) | 一种孕妇临产前适用的即食米粉及其制备方法和应用 | |
| Moghaddam-Banaem | Maternal Serum Iron and Zinc Levels and Gestational Diabetes | |
| Volodymyrivna et al. | DEPENDENCE OF VITAMIN DEFICIENCY IN PREGNANT WOMEN ON THE TERM OF PREGNANCY AND SEASON |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |